Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$85.36
-1.1%
$94.46
$81.97
$139.06
$150.32B0.6511.57 million shs21.14 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$73.74
+1.9%
$64.17
$54.11
$89.98
$27.91B1.46.97 million shs9.26 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,105.37
-1.9%
$955.92
$623.78
$1,149.10
$1.06T0.483.09 million shs4.60 million shs
Medtronic PLC stock logo
MDT
Medtronic
$73.73
-2.4%
$82.36
$73.67
$106.33
$97.02B0.629.39 million shs22.23 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$45.57
+0.1%
$40.98
$35.12
$81.44
$203.51B0.7714.57 million shs10.97 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.97%-2.36%-6.74%-26.53%-35.36%
DexCom, Inc. stock logo
DXCM
DexCom
+1.94%+2.27%+28.11%+0.42%-15.22%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-1.89%+3.64%+29.79%+5.23%+53.82%
Medtronic PLC stock logo
MDT
Medtronic
-2.42%-6.27%-7.05%-24.46%-9.27%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+0.15%+1.48%+13.14%+21.54%-33.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$85.36
-1.1%
$94.46
$81.97
$139.06
$150.32B0.6511.57 million shs21.14 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$73.74
+1.9%
$64.17
$54.11
$89.98
$27.91B1.46.97 million shs9.26 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,105.37
-1.9%
$955.92
$623.78
$1,149.10
$1.06T0.483.09 million shs4.60 million shs
Medtronic PLC stock logo
MDT
Medtronic
$73.73
-2.4%
$82.36
$73.67
$106.33
$97.02B0.629.39 million shs22.23 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$45.57
+0.1%
$40.98
$35.12
$81.44
$203.51B0.7714.57 million shs10.97 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.97%-2.36%-6.74%-26.53%-35.36%
DexCom, Inc. stock logo
DXCM
DexCom
+1.94%+2.27%+28.11%+0.42%-15.22%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-1.89%+3.64%+29.79%+5.23%+53.82%
Medtronic PLC stock logo
MDT
Medtronic
-2.42%-6.27%-7.05%-24.46%-9.27%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
+0.15%+1.48%+13.14%+21.54%-33.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.0939.52% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.92
Moderate Buy$82.4211.77% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,227.0011.00% Upside
Medtronic PLC stock logo
MDT
Medtronic
2.58
Moderate Buy$106.4544.38% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.13
Hold$65.5643.86% Upside

Current Analyst Ratings Breakdown

Latest DXCM, MDT, NVO, ABT, and LLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingBuy$79.00 ➝ $84.00
5/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$121.00 ➝ $113.00
5/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,133.00 ➝ $1,251.00
5/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Set Price Target$1,119.00
5/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingBuy$1,283.00
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
DowngradeHold (C+)Hold (C)
5/21/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,350.00
5/21/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
Set Price TargetNeutral$84.00
5/21/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price Target$1,300.00 ➝ $1,330.00
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
UpgradeHold$84.00
(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.35$6.91 per share12.35$30.26 per share2.82
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.10$2.82 per share26.13$7.66 per share9.63
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B15.97$24.66 per share44.83$33.13 per share33.36
Medtronic PLC stock logo
MDT
Medtronic
$33.54B2.82$7.56 per share9.75$37.62 per share1.96
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$327.80B0.62$4.69 per share9.71$7.12 per share6.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5723.9114.091.4413.90%17.62%10.01%7/16/2026 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.3431.5124.421.2019.31%33.33%13.19%7/29/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$28.1539.2724.941.2334.98%105.77%23.76%8/5/2026 (Estimated)
Medtronic PLC stock logo
MDT
Medtronic
$4.66B$3.5920.5412.131.8013.00%14.82%7.88%6/3/2026 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$4.2610.7013.254.0637.23%63.31%22.19%8/5/2026 (Estimated)

Latest DXCM, MDT, NVO, ABT, and LLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/3/2026Q4 2026
Medtronic PLC stock logo
MDT
Medtronic
$1.54N/AN/AN/A$9.62 billionN/A
5/6/2026Q1 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.87$1.04+$0.17$1.69$10.86 billion$10.85 billion
4/30/2026Q1 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billion
4/30/2026Q1 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
3/31/2026Q1 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
N/A$1.0270N/A$1.69N/A$10.85 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.95%+10.39%70.59%54 Years
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.63%+15.18%24.58%11 Years
Medtronic PLC stock logo
MDT
Medtronic
$2.843.85%+5.33%79.11%49 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.743.82%+21.74%40.85%N/A

Latest DXCM, MDT, NVO, ABT, and LLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.69%5/15/20265/15/20266/10/2026
3/5/2026
Medtronic PLC stock logo
MDT
Medtronic
quarterly$0.713.26%3/27/20263/27/20264/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
DexCom, Inc. stock logo
DXCM
DexCom
0.42
1.95
1.64
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.26
1.50
1.10
Medtronic PLC stock logo
MDT
Medtronic
0.57
2.54
1.87
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.59
0.79
0.56

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Medtronic PLC stock logo
MDT
Medtronic
82.06%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Medtronic PLC stock logo
MDT
Medtronic
0.26%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000385.87 million384.79 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.74 million940.42 millionOptionable
Medtronic PLC stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable

Recent News About These Companies

CVS Restores Coverage for Lilly's Zepbound
Eli Lilly Jumps as CVS Expands Weight-Loss Drug Coverage
CVS will add these weight-loss options to drug plans
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$85.36 -0.94 (-1.09%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$85.55 +0.20 (+0.23%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

DexCom stock logo

DexCom NASDAQ:DXCM

$73.74 +1.40 (+1.94%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$73.35 -0.39 (-0.53%)
As of 05/29/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,105.37 -21.43 (-1.90%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$1,105.00 -0.37 (-0.03%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Medtronic stock logo

Medtronic NYSE:MDT

$73.73 -1.84 (-2.44%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$74.16 +0.43 (+0.58%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$45.57 +0.06 (+0.14%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$45.56 -0.01 (-0.03%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.